Jamie Rich

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Jamie Rich
Dec 25, 2024, 22:43 | History
Raffaele Colombo: A record 77 new ADCs entered clinical development in 2024
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks Inc., shared a post on X…
Nov 7, 2024, 16:03 | Insight
The journey of ADCs is a story of perseverance
An article by Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks Inc., was recently…
Nov 5, 2024, 15:59 | Blog
Elizabeth McKenna: The November issue of Cancer Discovery is now online
Elizabeth McKenna posted on X: "I'm so excited that the November issue of Cancer Discovery…
Oct 25, 2024, 16:47 | Blog
Key milestones and insights from the evolution of antibody-drug conjugates - Zymeworks Inc.
Zymeworks Inc. shared a post on Linkedin: ''We're proud to share a recent publication in…
Oct 25, 2024, 13:16 | Insight
Elizabeth McKenna: An overview of the past 4 decades of development of ADC’s
Elizabeth McKenna, Executive Editor of Cancer Discovery at American Association for Cancer Research, shared on…
Oct 25, 2024, 08:51 | Blog
Nirmit Kumar: Great overview of the history of Antibody Drug Conjugates by Raffaele Colombo et al.
Nirmit Kumar, Senior Global Medical Strategy Leader at AstraZeneca, shared a post by Paolo Tarantino…
Aug 23, 2024, 16:19 | Insight
How ADCs are redefining cancer treatment - Zymeworks Inc.
Zymeworks Inc. shared a post on LinkedIn: "Ongoing innovations in antibody-drug conjugates (ADCs) are revolutionizing cancer…
Apr 8, 2024, 15:15 | Blog
Raffaele Colombo: AACR Annual Meeting 2024 has started!
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on LinkedIn: "AACR Annual Meeting…
All: 8 Posts: 1 - 100
Special Coverage